Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Find out which option tends to yield steadier income—index funds or bonds—and how to blend them for reliability and growth.
24,934 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Alphabet unveiled a record $84.75B equity sale to fuel AI infrastructure. The move sent ripples through the stock mar...
Apple stock nears all-time as strong earnings and a growing Services business lift investor optimism. Here’s the late...
In a renewed push to accumulate, Strategy added 1,550 BTC for about $101 million in early June, boosting holdings to ...
I used to be skeptical about SoundHound AI, but new developments and strategic moves are making me reconsider. This a...
Investors are backing a new space economy led by SpaceX, with launch costs cratering and Starship on the horizon. Ind...
As AI infrastructure spending accelerates, legendary short seller chanos cautions that the rally could follow a dot-c...
Singapore is quietly becoming the region’s neutral AI hub, drawing both U.S. and Chinese firms to its labs, offices a...
A modest lottery win can change your day—until a receipt goes missing and suspicion rises. This article breaks down h...
Kraken and Maple launch a pioneering on-chain credit facility that lets institutions borrow against crypto holdings i...
Ripple wins preliminary approval to operate under MiCA in Luxembourg, but the path to a full MiCA license is far from...
Rocket Lab is pursuing a bold $8 billion strategy to merge rocket launches, satellites, and data services. Learn what...